title: Selective inhibition of mucosal serotonin as treatment for IBD?
authors.affiliation: Department of Gastroenterology & Hepatology and the Tytgat, Institute for Liver & Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands.
authors.forename: Alon D
authors.initials: AD
authors.lastname: Levin
authors.forename: Gijs R
authors.initials: GR
authors.lastname: van den Brink
mesh_terms: D000818:Animals; D003092:Colitis / Q000378:metabolism*; D015536:Down-Regulation / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects*; D007413:Intestinal Mucosa / Q000378:metabolism*; D008297:Male; D009474:Neurons / Q000378:metabolism*; D012701:Serotonin / Q000096:biosynthesis*
chemical_list: D004791:Enzyme Inhibitors; D012701:Serotonin
keywords: INFLAMMATORY BOWEL DISEASE; PHARMACOTHERAPY; SEROTONIN